521 Results for: "D( )-Galactose"
Anti-Galectin 3 Mouse Recombinant Antibody [clone: rLGALS3/7286]
Supplier: ANTIBODIES.COM
Recombinant mouse monoclonal [rLGALS3/7286] antibody to Galectin 3 for IHC-P with samples derived from human.
Expand 1 Items
Anti-B4GALT3 Rabbit Polyclonal Antibody
Supplier: ProSci Inc.
Anti-B4GALT3 Rabbit Polyclonal Antibody
Expand 1 Items
Anti-Galectin 3 Mouse Monoclonal Antibody [clone: 5C21]
Supplier: ANTIBODIES.COM
Mouse monoclonal (5C21) antibody to Galectin 3 for WB, ICC/IF and IHC with samples derived from Human, Rat and Mouse.
Expand 2 Items
Anti-Galectin 3 Mouse Recombinant Antibody [clone: rLGALS3/7286]
Supplier: ANTIBODIES.COM
Recombinant mouse monoclonal [rLGALS3/7286] antibody to Galectin 3 for IHC-P with samples derived from human.
Expand 1 Items
IPTG (isopropyl-β-D-thiogalactopyranoside) ≥98% (by HPLC on dried basis), Biotech Reagent, cGMP-manufactured, J.T.Baker®
Supplier: Avantor
Reduce risk in your bioprocessing applications with Avantor J.T.Baker brand cGMP manufactured IPTG.
Expand 3 Items
Anti-Galectin 3 Rabbit Recombinant Antibody [clone: LGALS3/7036R]
Supplier: ANTIBODIES.COM
Recombinant rabbit monoclonal [LGALS3/7036R] antibody to Galectin 3 for IHC-P with samples derived from human.
Expand 1 Items
Anti-Galectin 3 Rabbit Monoclonal Antibody [clone: ARC0542]
Supplier: ANTIBODIES.COM
Rabbit monoclonal [ARC0542] antibody to Galectin 3 for WB, IHC and IP with samples derived from Human, Mouse and Rat.
Expand 1 Items
Anti-Galectin 3 Rat Monoclonal Antibody [Clone: M3/38]
Supplier: ANTIBODIES.COM
Rat monoclonal [M3/38] antibody to Galectin 3 for WB, IHC-P, ICC, Flow cytometry and IP with samples derived from human and mouse.
Expand 1 Items
Anti-B3GNT3 Rabbit Polyclonal Antibody
Supplier: ProSci Inc.
Anti-B3GNT3 Rabbit Polyclonal Antibody
Expand 1 Items
Human Recombinant Galectin-1
Supplier: STEMCELL Technologies
Galectin-1 (Gal1) was the first characterized member of the galectin family of galactosidase-binding proteins, with over 15 mammalian galectins identified (Camby et al.; Salatino et al.). Gal1 comes in two forms: the oxidized monomer that acts as a cytokine, and the reduced dimer that acts as a lectin (Gaudet et al.). This product is in the dimer form. This cytokine is expressed in many tissues and has an immunosuppressive role in affecting T cell homeostasis by various mechanisms such as regulating apoptosis, cytokine secretion, cell adhesion, cell proliferation, and other effects (Camby et al.; Garín et al.; Gaudet et al.; Salatino et al.). In addition, Gal1 is thought to also play a role in axonal regeneration after injuries (Camby et al.; Garín et al.; Gaudet et al.; Salatino et al.). There are several therapeutic applications suggested for Gal1; overexpression has been suggested as a therapy for autoimmune and inflammatory diseases and enhancing axonal regeneration in injured nerves (Camby et al.; Gaudet et al.). In contrast, inhibition of Gal1 has been suggested to prevent tumor metastasis and cancer progression, as it may aid in cell adhesion, migration, and immune escape of cancer cells (Camby et al.).
Expand 1 Items
Human Recombinant Galectin-3 (from E. coli)
Supplier: Shenandoah Biotechnology
Galectin-3 belongs to the lectin family of carbohydrate binding proteins. Galectin-3 is expressed by a wide range of cell types including activated T cells, tumor cells, macrophages, osteoclasts, fibroblasts, and epithelial cells. Galectin-3 has specific binding affinity for beta-galactoside sugar moieties and has functional roles during development, innate immunity, cell apoptosis, and tumor metastasis. Galectin-3 is associated with cancer, heart failure, stroke, and inflammation. The amino acid sequences of human and mouse Galectin-3 proteins share 80% homology.